- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04037306
Measurements From Stool to Support Dietary Change
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a research study to find out how people respond to information about food-derived compounds measured in their stool.
This study will take place over a three-week period. For these three weeks, participants in a medical weight loss program will be asked to collect samples of their stool daily from Monday to Friday, with optional sampling on weekends. We will measure the amount of butyrate, a breakdown product of fiber, in each sample provided and return this measurement by text message. Participants will be randomized into two groups: one group will have new measurements returned the day after providing each stool sample, and another will have their measurements returned all at once, at the end of the study. Both groups will also receive a daily text message report of their fiber intake, based on the foods they ordered at the weight loss facility cafeteria.
The greatest risks of the study include the possibility of infection while sampling stool, possible gastrointestinal discomfort from changes to the diet, and potential loss of confidentiality.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27708
- Duke University Diet and Fitness Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- between the ages of 18 and 80
- must be a client of the DFC (Duke Diet and Fitness Center) weight loss program for at least four continuous weeks.
- must have a smartphone
Exclusion Criteria:
- have diagnosis of Crohn's disease
- have known stricture (narrowing) of the intestine
- have any past history of intestinal obstruction
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Rapid Feedback
Participants received daily feedback on both fiber intake and stool butyrate measurements.
|
Measure concentrations of stool butyrate by gas chromatography, returned to participants in summary report.
Estimated fiber consumption from menu records of weight loss facility.
|
Active Comparator: Delayed Feedback
Participants received daily feedback on fiber intake and one-time feedback on stool butyrate measurements at the end of the study period.
|
Measure concentrations of stool butyrate by gas chromatography, returned to participants in summary report.
Estimated fiber consumption from menu records of weight loss facility.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in nutrient intake, as estimated from menu selections
Time Frame: Baseline, Week 2, and Week 3
|
Nutrient intake estimated in grams per day, summed over total menu selections.
|
Baseline, Week 2, and Week 3
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in butyrate concentration
Time Frame: Baseline, Week 2, and Week 3
|
Butyrate measurements by gas chromatography, reported in mM (millimolar).
|
Baseline, Week 2, and Week 3
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Pro00094657
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Feeding Behavior
-
Centre Hospitalier Intercommunal CreteilCompletedFeeding Behavior | Feeding, BottleFrance
-
Sakarya UniversityNot yet recruitingBreast Feeding | Feeding BehaviorTurkey
-
Taipei Medical UniversityCompletedBreast Feeding | Self Efficacy | Feeding BehaviorIndonesia
-
The University of Tennessee, KnoxvilleWithdrawnFeeding Behavior | Behavior | Food Habits | Behavior and Behavior MechanismsUnited States
-
Penn State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedFeeding BehaviorUnited States
-
Penn State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Penn State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); United...Completed
-
University of Colorado, DenverTemple University; Vitamix FoundationRecruiting
-
Penn State UniversityJenny Craig, Inc.Completed
-
Iowa State UniversityCompleted
Clinical Trials on Butyrate Feedback
-
Children's Hospital Los AngelesRecruiting
-
Unilever R&DLeiden University Medical CenterCompleted
-
Maastricht University Medical CenterCompleted
-
Federico II UniversityCompleted
-
Maastricht University Medical CenterCompleted
-
University of MichiganEnrolling by invitationDepression | Anxiety | Sleep Disturbance | AddictionUnited States
-
University Hospital, CaenUnknown
-
Northwestern UniversityCompletedAutism Spectrum Disorder | AutismUnited States